Press release
Cushing’s Syndrome Therapeutics - Key Players Analysis Novartis, AstraZeneca, Cyclacel Pharmaceuticals, Inc., Angion Biomedica Corp.
Browse report sample at: https://www.psmarketresearch.com/market-analysis/cushing-syndrome-therapeutics-pipeline-analysis/report-sample
*Specific Targeted Therapy to Provide Various Opportunities
The drug development process involves specific target such as steroid 11-beta-hydroxylase, which is the probable mechanism of action for the treatment of Cushing’s syndrome. Thus, this specific targeted therapy provides opportunities to the companies for better and targeted drug development.
Some of the players developing drugs for the treatment of Cushing’s syndrome include Novartis AG, AstraZeneca Plc, Cyclacel Pharmaceuticals, Inc., and Angion Biomedica Corp.
Access Report Summary With Detailed TOC on “Cushing’s Syndrome Therapeutics - Pipeline Analysis 2017 at: https://www.psmarketresearch.com/market-analysis/cushing-syndrome-therapeutics-pipeline-analysis
*Insights on pipeline segments
Orphan drug designations from the European Medicines Agency (EMA) is the one of the drivers for the development of pipeline drugs of Cushing’s syndrome. Majority of the pipeline drug candidates are being developed using the oral route of administration. Osilodrostat which is being developed by the Novartis AG is in the Phase III stage of development for the treatment of Cushing’s syndrome.
About P&S Intelligence
P&S Intelligence, a brand of P&S Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.
Contact:
P&S Intelligence
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cushing’s Syndrome Therapeutics - Key Players Analysis Novartis, AstraZeneca, Cyclacel Pharmaceuticals, Inc., Angion Biomedica Corp. here
News-ID: 1416989 • Views: …
More Releases from Prescient & Strategic Intelligence
Global Automation Market Set to Reach $161.6 Billion by 2030: AI and IoT Drive I …
According to the latest market research study published by P&S Intelligence, the global automation market will generate an estimated revenue of USD 129.5 billion in 2024, which is expected to witness a CAGR of 3.8% during 2024-2030, to reach USD 161.6 billion by 2030. The most significant driving force behind the growth of the market is the technological development occurring in the world and the need for improvement of different…
Market Trends in Marine Onboard Communication and Control Systems
In 2023, the global market for marine onboard communication and control systems reached USD 8,733.2 million, projected to grow to USD 14,496.2 million by 2030, with a compound annual growth rate (CAGR) of 7.7%.
This growth is driven by several factors including increased emphasis on fleet modernization, expanding global trade, and advancements in control solutions and marine communication technologies. There is also a growing demand for higher automation and connectivity in…
Biobanking Services Market by Biobank Type, Service Type, Ownership, Application …
The global biobanking services market is expected to broaden during the forecast period, mainly on account of growing prevalence of chronic diseases, use of blood biomarkers in early detection of various types of cancersincreasing genomic research activities for studying diseases, growing trend of conserving cord blood stem cells of newborns, surging government and private funding to support regenerative medicine research, and growing need for cost-effective drug discovery and development.
Download free…
Patient Engagement Solutions Market 2013-2023 by Key Companies are - athenahealt …
The patient engagement solutions market for software is expected to reach $12.3 billion by 2023, registering a CAGR of 16.6% during the forecast period. Patient engagement software is increasingly being adopted by healthcare facilities, as it helps simplify complex patient health data and can also be customized according to requirements.
Download free report sample at: https://www.psmarketresearch.com/market-analysis/patient-engagement-solutions-market/report-sample
During the forecast period, the patient engagement solutions market is expected to witness the highest demand…
More Releases for Cushing’s
The Cushing’s Disease Treatment Market to grow at an invigorating pace in the …
Cushing disease is caused by tumour in the pituitary gland which leads to excessive secretion of a hormone called adrenocorticotrophic (ACTH), which in turn leads to increasing levels of cortisol in the body. Cortisol is a steroid hormone released by the adrenal glands and helps the body to deal with injury or infection. Increasing levels of cortisol increases the blood sugar and can even cause diabetes mellitus. However the disease…
Cushing’s syndrome Market Report Analysis With Industry Share
Cushing’s syndrome is the collection of symptoms caused due to the high level of hormones called cortisol. Also known as hypercortisolism, the syndrome is often caused due to side effects of corticosteroid treatment. Corticosteroids are often used for treatment of inflammation and autoimmune conditions. Cushing’s syndrome can be of two types, iatrogenic Cushing’s syndrome and endogenous Cushing’s syndrome. Common symptoms of the syndrome include weight gain, fat tissue deposits around…
Cushing’s Syndrome Market Is Projected to Increase Due To Rise in Its Awarenes …
Cushing’s Syndrome is a collection of symptoms and signs, which includes high blood pressure, reddish stretch marks, abdominal obesity, round red face, weak muscles, weak bones, a fat lump between the shoulders and fragile skin that heals slowly due to prolonged exposure to cortisol. Excessive cortisol-like medication such as prednisone or tumor that is produced due to excess cortisol by adrenal glands are the two basic factors that cause Cushing’s…
Cushing’s Disease Treatment Market Forecast over 2017 – 2025
Cushing disease is caused by tumour in the pituitary gland which leads to excessive secretion of a hormone called adrenocorticotrophic (ACTH), which in turn leads to increasing levels of cortisol in the body. Cortisol is a steroid hormone released by the adrenal glands and helps the body to deal with injury or infection. Increasing levels of cortisol increases the blood sugar and can even cause diabetes mellitus. However the disease…
Cushing’s Disease Treatment Market Forecast over 2017 – 2025
Cushing disease is caused by tumour in the pituitary gland which leads to excessive secretion of a hormone called adrenocorticotrophic (ACTH), which in turn leads to increasing levels of cortisol in the body. Cortisol is a steroid hormone released by the adrenal glands and helps the body to deal with injury or infection. Increasing levels of cortisol increases the blood sugar and can even cause diabetes mellitus. However the disease…
Cushing’s Disease Treatment Market Set to Surge Significantly During 2017 - 20 …
Cushing disease is caused by tumour in the pituitary gland which leads to excessive secretion of a hormone called adrenocorticotrophic (ACTH), which in turn leads to increasing levels of cortisol in the body. Cortisol is a steroid hormone released by the adrenal glands and helps the body to deal with injury or infection. Increasing levels of cortisol increases the blood sugar and can even cause diabetes mellitus. However the disease…
